Crossref journal-article
Wiley
Small (311)
Abstract

AbstractMesoporous silica nanoparticles (MSNs) are a promising material for drug delivery. In this Full Paper, MSNs are first shown to be well tolerated, as demonstrated by serological, hematological, and histopathological examinations of blood samples and mouse tissues after MSN injection. Biodistribution studies using human cancer xenografts are carried out with in vivo imaging and fluorescent microscopy imaging, as well as with inductively coupled plasma mass spectroscopy. The results show that MSNs preferentially accumulate in tumors. Finally, the drug‐delivery capability of MSNs is demonstrated by following tumor growth in mice treated with camptothecin‐loaded MSNs. These results indicate that MSNs are biocompatible, preferentially accumulate in tumors, and effectively deliver drugs to the tumors and suppress tumor growth.

Bibliography

Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010). Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals. Small, 6(16), 1794–1805. Portico.

Authors 5
  1. Jie Lu (first)
  2. Monty Liong (additional)
  3. Zongxi Li (additional)
  4. Jeffrey I. Zink (additional)
  5. Fuyuhiko Tamanoi (additional)
References 49 Referenced 946
  1. 10.1021/ja901831u
  2. 10.1016/j.yexmp.2008.12.004
  3. 10.1016/j.biomaterials.2009.09.048
  4. 10.1111/j.1551-2916.2008.02722.x
  5. 10.2174/138955708783498078
  6. 10.1002/smll.200700903
  7. 10.1002/smll.200700005
  8. 10.1021/nn900918w
  9. 10.1021/ja809346n
  10. 10.1002/chem.200900851
  11. 10.1016/j.biomaterials.2007.03.006
  12. 10.1021/jp064941v
  13. 10.1021/ja0645943
  14. 10.1039/b900559e
  15. 10.1039/b701744h
  16. 10.1021/ja028650l
  17. 10.1039/b904197d
  18. 10.1021/ol0612509
  19. 10.1021/ja0772086
  20. 10.1021/ja807798g
  21. 10.1002/anie.200705211
  22. 10.1021/nn700008s
  23. 10.1021/ja046275m
  24. 10.1007/978-1-59745-483-4_34
  25. 10.1016/j.addr.2008.03.012
  26. 10.1038/nnano.2007.108
  27. 10.1166/jnn.2005.146
  28. 10.1021/ja070245c
  29. 10.1021/nn800072t
  30. 10.1021/ja904982j
  31. 10.1021/ja9010157
  32. 10.1039/b910431c
  33. 10.1039/b9nr00162j
  34. 10.1002/anie.200805149
  35. 10.1002/smll.200700493
  36. 10.1002/smll.200701316
  37. 10.1002/anie.200802469
  38. 10.1016/j.biomaterials.2008.07.007
  39. {'key': 'e_1_2_7_39_2', 'first-page': '6387', 'volume': '46', 'author': 'Matsumura Y.', 'year': '1986', 'journal-title': 'Cancer Res.'} / Cancer Res. by Matsumura Y. (1986)
  40. {'key': 'e_1_2_7_40_2', 'first-page': '7', 'volume': '5', 'author': 'Muggia F. M.', 'year': '1999', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. by Muggia F. M. (1999)
  41. 10.1021/cm0210041
  42. 10.1007/s12030-008-9003-3
  43. {'key': 'e_1_2_7_43_2', 'first-page': '319', 'volume': '49', 'author': 'Ullman‐Cullere M. H.', 'year': '1999', 'journal-title': 'Lab. Anim. Sci.'} / Lab. Anim. Sci. by Ullman‐Cullere M. H. (1999)
  44. 10.1021/ac801882g
  45. 10.1158/1535-7163.1505.3.12 / Mol. Cancer Ther. by Jhaveri M. S. (2004)
  46. 10.1002/adma.200801395
  47. 10.1165/rcmb.2006-0319OC
  48. 10.1021/nl803405h
  49. 10.1002/(SICI)1097-0320(19961101)25:3<271::AID-CYTO8>3.0.CO;2-I
Dates
Type When
Created 15 years, 1 month ago (July 13, 2010, 6:28 a.m.)
Deposited 1 year, 10 months ago (Oct. 7, 2023, 7:40 a.m.)
Indexed 6 days, 8 hours ago (Aug. 26, 2025, 2:25 a.m.)
Issued 15 years, 1 month ago (July 7, 2010)
Published 15 years, 1 month ago (July 7, 2010)
Published Online 15 years, 1 month ago (July 7, 2010)
Published Print 15 years ago (Aug. 16, 2010)
Funders 0

None

@article{Lu_2010, title={Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals}, volume={6}, ISSN={1613-6829}, url={http://dx.doi.org/10.1002/smll.201000538}, DOI={10.1002/smll.201000538}, number={16}, journal={Small}, publisher={Wiley}, author={Lu, Jie and Liong, Monty and Li, Zongxi and Zink, Jeffrey I. and Tamanoi, Fuyuhiko}, year={2010}, month=jul, pages={1794–1805} }